1. To evaluate In vivo molecular-structural imaging demonstrated that atorvastatin significantly reduced fibrin deposition at day 7 and macrophage accumulation at days 7 and 14, findings supported by histopathologic and gene-expression analyses.
2. To determine clinical significance of study results.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation